Background: The objective of the second Dyslipidemia International Study (DYSIS II) was to document use of lipid-lowering therapies (LLTs), LDL-C target value attainment (LDL-C Click to show full abstract
Background: The objective of the second Dyslipidemia International Study (DYSIS II) was to document use of lipid-lowering therapies (LLTs), LDL-C target value attainment (LDL-C <70 mg/dL) at the time of the acute event and at 4-months follow-up in patients with acute coronary syndrome (ACS).
               
Click one of the above tabs to view related content.